Gil M. Labrucherie, SVP, COO & CFO at NEKTAR THERAPEUTICS (NKTR), sold 34,896 shares at $3.95 ($138K) on 2022-05-16, disclosed to the SEC on 2022-05-17.
Seasonal sale ($138k) by SVP, COO & CFO — this insider has traded NKTR in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.95 | 17,448 | $69K | 50.0% |
| 2 | $3.95 | 17,448 | $69K | 50.0% |
| Total | $3.95 avg | 34,896 | $138K | 100% |
| Filing → |
| RZLT | BUY | 2022-05-09 | $400K | — | Filing → |
| NKTR | SELL | 2022-02-18 | $166K | — | Filing → |
| NKTR | SELL | 2021-11-18 | $595K | — | Filing → |